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Abstract
Background: A continuing controversy exists about whether, asbestos exposure is associated with significant lung
function impairments when major radiological abnormalities are lacking. We conducted a systematic review and
meta-analysis in order to assess whether asbestos exposure is related to impairment of lung function parameters
independently of the radiological findings.
Methods: MEDLINE was searched from its inception up to April 2010. We included studies that assessed lung
function parameters in asbestos exposed workers and stratified subjects according to radiological findings.
Estimates of VC, FEV1 and FEV1/VC with their dispersion measures were extracted and pooled.
Results: Our meta-analysis with data from 9,921 workers exposed to asbestos demonstrates a statistically significant
reduction in VC, FEV1 and FEV1/VC, even in those workers without radiological changes. Less severe lung function
impairments are detected if the diagnoses are based on (high resolution) computed tomography rather than the
less sensitive X-ray images. The degree of lung function impairment was partly related to the proportion of
smokers included in the studies.
Conclusions: Asbestos exposure is related to restrictive and obstructive lung function impairment. Even in the
absence of radiological evidence of parenchymal or pleural diseases there is a trend for functional impairment.
Keywords: Asbestos, lung function, chest X-ray, computed tomography, meta-analysis
Introduction
Asbestos fibres are one of the most pervasive environ-
mental hazards because of their worldwide use in the
last 100 years as a cheap and effective thermal, sound
and electrical insulation material, especially in the con-
struction, shipping and textile industries. The general
public is also exposed to asbestos, mainly from dete-
rioration and reconstruction or destruction of asbestos
contaminated buildings, worn vehicle brake linings and
from the deterioration of asbestos-containing products.
In spite of outright bans or restrictions in nearly all
industrialised countries nowadays, approximately 125
million workers are occupationally exposed to asbestos
worldwide [1] and it is estimated that at least 100,000
die annually from complications of asbestos exposure
[2]. In addition to mesothelioma, lung and laryngeal
cancer, asbestos has long been known to cause non-
malignant pleural fibrosis, (i.e. circumscript pleural pla-
ques (PP), or diffuse pleural thickening (DPT)), pleural
effusions, rounded atelectasis and lung fibrosis (asbesto-
sis). Since inhalation of high doses of asbestos fibres
may lead to a variety of functional impairments, the
monitoring of workers who have been exposed to asbes-
tos, particularly of their lung function, has gained in
importance over the years. The identification of func-
tional abnormalities is also relevant for compensation
issues. While compromised lung function in pronounced
disease is widely accepted, controversies still remain
about a possible relationship between earlier or milder
non-malignant asbestos-induced pleural or parenchymal
fibrosis and reduced lung function measurements [3-11].
The American Thoracic Society and the American Col-
lege of Chest Physicians [12,13], in particular, have
lamented the lack of definitive knowledge in the preva-
lence and clinical relevance of asbestos-induced obstruc-
tive airway diseases and have determined to make this a
priority for investigation and elucidation.
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analysis of the literature with the aim of identifying and
quantifying alterations of lung function parameters in
subjects occupationally exposed to asbestos. The leading
question was whether occupational exposure to asbestos
leads to impairments of lung function independently
from the non-malignant radiological findings (i.e. nor-
mal chest radiograph (X-ray) or (high resolution) com-
puted tomography (HR)CT, pleural plaques and diffuse
pleural thickening or asbestosis).
Materials and methods
Selection criteria
We included publications that assessed lung function
parameters and radiological imaging (chest X-Ray or
(HR)CT) in persons with occupational exposure to
asbestos. Only studies that applied an internationally
accepted quality standard for lung function testing (i.e.
ATS standard, ERS standard) and that provided infor-
mation about the corresponding reference values or
used reference group were considered. We included
only studies reporting lung function parameters
expressed as percent-predicted with a corresponding
dispersion measure (i.e. standard deviation, standard
error or confidence interval) and assigned them to one
of the following radiological categories:
A. “Normal imaging”, i.e. absence of pleural or lung
parenchymal abnormalities.
B. “Pleural fibrosis”,i . e .p r e s e n c eo fp l e u r a lp l a q u e s
and/or diffuse pleural thickening.
C. “Asbestosis”, i.e. parenchymal fibrosis with or
without pleural fibrosis.
To be included, studies had to provide data on the
proportion of smokers among participants or on the
dose (pack-years).
In a few potentially relevant studies the authors failed to
report all information listed above (e.g. reference values,
quality standards, dispersion measures), thus we tried to
contact the authors in order to collect the missing data.
Only three authors sent additional information that enabled
us to include their publication in the meta-analysis.
Search strategy
MEDLINE was searched from its inception to April
2010 via PubMed with the following search strategy:
("Asbestosis"[Mesh] OR ("Pleural Diseases"[Mesh]
AND “Asbestos"[Mesh]) OR ("occupational exposure"
[Mesh] AND “Asbestos"[Mesh]) OR ("Lung diseases"
[Mesh] AND “Asbestos"[Mesh])) AND “Respiratory
Function Tests"[Mesh] AND ("occupational diseases"
[Mesh] OR “occupational health"[Mesh] OR “occupa-
tional exposure"[Mesh])
We applied the following PubMed limits in order to
increase the specificity of our search:
("humans"[MeSH Terms] AND (English[lang] OR
German[lang]) AND “adult"[MeSH Terms]) NOT
("Bronchoalveolar Lavage"[MeSH] OR “Neoplasms"[-
Mesh] OR “Case Reports “[Publication Type]).
Additionally, we scanned congress proceedings, refer-
ence lists of relevant articles and searched our own
archive for further potentially relevant publications not
identified through the electronic search.
Data extraction
We extracted information on sample size, exposure to
asbestos, proportion of non-smokers, radiological ima-
ging method and lung function reference values together
with the estimates for vital capacity (VC), forced expira-
tory volume in the first second (FEV1)a n dF E V 1/VC
with their corresponding SD, SE or 95% CI. Most of the
studies reported forced vital capacity (FVC), but in some
papers it was not clear whether FVC or slow (relaxed)
vital capacity (SVC) was measured. Data were extracted
by at least two of the authors independently from each
other and discrepancies were solved by consensus after
discussion. (HR)CT-based diagnoses were favoured over
those based on X-rays when both were available.
Data synthesis and statistical methods
We performed a meta-analysis to produce pooled esti-
mates of VC, FEV1 and FEV1/VC for each of our desig-
nated radiological categories (A, B or C). Within each
radiological category, we conducted subgroup analysis
according to the type of imaging method used for the
diagnosis (X-ray or (HR)CT).
Some studies reported results for different degrees of
radiological impairments within the same category (e.g.
different ILO scores for asbestosis). In these cases, we
p o o l e dt h es u b g r o u pe s t i m a t e sf r o mt h es a m es t u d y
with a fixed effects model to obtain a single estimate for
each study within each radiological category (A-C).
A random effects model was used to calculate overall
estimates for each radiological category.
We calculated I
2 as an indicator for the degree of het-
erogeneity across studies. Values of I
2 under 25% indi-
cate low, up to 60% medium and over 75% considerable
heterogeneity, making it advisable to perform the analy-
sis using the random effects model [14]. In order to
assess whether any observed between-study heterogene-
ity could be explained through study characteristics
other than radiological imaging procedure, we also per-
formed subgroup analysis for the proportion of never-
smokers. For this purpose, we divided the study pool
into two categories: studies with <25% of participants
reporting to have never-smoked and studies with >=
25% of participants reporting to have never-smoked.
Wilken et al. Journal of Occupational Medicine and Toxicology 2011, 6:21
http://www.occup-med.com/content/6/1/21
Page 2 of 16A second subgroup analysis was done for mean dura-
tion of asbestos exposure, dividing the study pool into
two categories: studies reporting mean exposure dura-
tion longer than the median duration of the whole sam-
ple vs. studies with mean exposure duration shorter
than median duration. In addition, we performed meta-
regression analysis with the proportion of never-smokers
and with the years of asbestos-exposed occupation.
All calculations were performed with the software
Comprehensive Meta-Analysis 2.0. (Biostat™,E n g l e -
wood, USA). Forest plot graphics were produced with
Meta-Analyst Software [15]
Results
A total of 542 papers were identified by the electronic
literature database search and a further 46 papers
through manual searching in congress reports, reference
scanning and from our own archive (Figure 1). After
scanning titles and abstracts, 289 articles were selected
for a detailed assessment of the full publication. From
these 289 articles, 30 met the inclusion criteria for the
meta-analysis. The most frequent reasons for exclusion
were lack of information about lung function parameters
and/or about radiological diagnoses and lack of report-
ing statistical dispersion measures.
We included 27 cross-sectional studies, one case-
control and two follow-up studies, comprising a total
of 15,097 subjects of which the data for 9,921 were
reported appropriately for inclusion in our meta-analy-
sis. The characteristics of the included studies are
shown in Table 1. Sample size ranged from 19 to
3,383. Some studies focussed on a specific occupation
(e.g. asbestos manufacturing, insulation and cladding
work, shipyard, asbestos industries, asbestos cement
factory, ceiling tiles and wallboards, railway, ironwor-
ker, sheet metal, construction carpenters and mill-
wrights) while others included subjects from different
occupational fields. The mean duration of occupational
exposure to asbestos was reported in 22 studies (i.e.
7 3 %o ft h es t u d ys a m p l e )a n dr a n g e df r o m8 . 4±6 . 1t o
32.7 ± 6.7 years (mean ± SD). The latency time (i.e.
the time since first exposure) was reported in only 9
studies (i.e. 30%) and ranged from 24.5 ± 5.7 to 43.3 ±
6.7 years (mean ± SD). Estimations of asbestos fibre
concentration (i.e. fibre-years) were reported only
rarely [16,17].
Except for two studies [18,19], all included current
and/or former smokers. The proportion of participants
reporting to be never-smokers ranged across the studies
from only 3% to 100% (median 26.2%), with three stu-
dies not reporting the proportion of never-smokers.
Smoking severity was reported in 18 of the studies that
included smokers and ranged from 14.0 ± 11.9 to 38.9 ±
29.4 pack-years (mean ± SD).
Radiological imaging was done relying exclusively on
chest X-ray in 15 studies and relying exclusively on CT
or HRCT in 7 studies. Eight studies considered both
chest X-ray and CT/HRCT. Mainly VC, FEV1 or FEV1/
VC, or combinations of these parameters, were reported.
Some studies provided additional parameters, but due to
their scarcity and heterogeneity in assessment methods
we did not include them in the meta-analysis. In all stu-
dies, lung function test results were acquired according
to a quality standard, with the majority (67%) following
the American Thoracic Society (ATS) standard proce-
dure available at the time. There was considerable het-
erogeneity regarding the reference values used to
calculate “percent of predicted”, with a total of 12 differ-
ent reference values used across the included studies.
The most frequently used reference values were those
proposed by Quanjer 1983/1993 [20,21] (n = 5 studies),
followed by those of the ATS [22] and Knudson 1983
[23] (both in 4 studies each).
Quantitative data synthesis
Figures 2, 3 and 4 provide an overview of the pooled
estimates of lung function parameters according to radi-
ological findings.
Vital capacity
Vital capacity (VC, FVC) was the parameter most com-
monly reported in an adequate manner for inclusion in
our meta-analysis. Overall, asbestos-exposed workers
showed an impairment of vital capacity when compared
with reference values (Figure 2). This impairment of
vital capacity was already manifest in workers without
radiological evidence of asbestos-related pleural or par-
enchymal diseases (95.7%-predicted; 95%-CI 93.9, 97.3).
The loss of vital capacity was most accentuated in sub-
jects with radiological findings of asbestosis (86.5%-pre-
dicted; 95%-CI 83.7, 89.4). The subgroup analysis based
on the radiological procedure showed lower estimates of
vital capacity in all three radiological categories among
studies using conventional chest X-ray compared with
those using (HR)CT (Table 2).
Heterogeneity was very high in all three radiological
subgroups (I
2 >90%) and remained after subgroup analy-
sis according to radiological procedure.
FEV1
As for vital capacity, asbestos-exposed workers showed
an impairment of FEV1 which was already present in
workers with no radiological evidence of asbestos-
related disease and was considerably more pronounced
in subjects with radiological signs of asbestos-related
pleural and/or parenchymal diseases (Figure 3). Again,
the subgroup analysis showed differences between stu-
dies using chest X-ray and studies using (HR)CT (Table
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were particularly pronounced for subjects identified as
having asbestos-related pleural disease. For this group of
patients, the estimate of FEV1 obtained from the sub-
group of studies using conventional X-ray was about 10
percent lower than estimate obtained from HR(CT) stu-
dies (83.9%-predicted; 95% CI 77.2, 90.5 vs. 93.7%-pre-
dicted; 95% CI 87.6, 99.9) (Table 2).
Heterogeneity was also very high for these analysis (I
2
>90%), but decreased to some extent when grouping
studies according to radiological technique.
FEV1/VC
FEV1/VC was less commonly reported in an adequate
manner for inclusion in our analysis. Slight FEV1/VC
reductions were already seen in workers even without
radiological signs of disease, and were similar to those
seen for workers with evidence of pleural disease and
for those with signs of lung fibrosis related to asbestos
(Figure 4). As for the other lung function parameters,
there were differences between studies according to the
radiological method used, with a tendency to lower
FEV1/VC among the studies using chest X-ray.
Figure 1 Flow chart - Study selection process.
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Page 4 of 16Table 1 Characteristics of included studies
Reference Study
type
Study
size
N (in meta-
analysis)
Asbestos exposure Smoking habits Radiological
chest imaging
Lung function
Occupation Duration
(yr)
Latency
(yr)
non
smokers
(%)
Pack-years Quality
requirements
Reference values
mean SD Mean SD mean SD
Ameille et al. 2004 [70] CS 287 228 asbestos
industry
25.8 9.4 33.2 9.4 38.1 nr nr HRCT ATS 1987 ATS 1987
Begin et al. 1993 [71] CS 61 46 asbestos
industry
22.0 15.6§ nr nr 21.3 28.0 23.4§ X-ray/HRCT Bates 1971 Bates 1971
Begin et al. 1995 [72] CS 207 96 diverse 26.0 13.7§ nr nr 13.5 29.4 20.6§ X-ray/HRCT Bates 1971 Bates 1971
Van Cleemput et al.
2001 [16]
CS 94 73 asbestos
industry
25.0 1.4 nr nr 15.0 10.9 20.6 HRCT ECSC/ERS Quanjer 1993
Delpierre et al. 2002 [55] CS 97 38 asbestos
industry
19.0 2.0 nr nr 37.0 nr nr X-ray Quanjer 1983 Quanjer 1993
Garcia-Closas and
Christiani 1995 [60]
CS 631 541 construction/
millwright
20.0 10.2 nr nr 33.1 24.1 21.3 X-ray ATS 1987 Crapo 1981
Hall and Cissik 1982 [24] CS 135 113 diverse #18.0 11.2 nr nr 40.7 #21.2 19.5 X-ray (ATS) OSHA
1978
Knudson 1983
Harkin et al. 1996 [73] CS 107 37 diverse nr nr 32.5 9.5§ 21.6 29.2 23.3§ X-Ray/HRCT ATS 1986 Knudson 1983
Jarad et al. 1992 [74] CS 60 60 diverse 10m 1-35r 34m 21-
60r
13.3 21m 0-76r X-Ray/HRCT ATS 1979
(Cotes)
Cotes 1979
Kee et al. 1996 [75] CC 1150 93 shipyard/
construction
25.5 12.1 41 11.3 nr 23.9 25.7 HRCT ATS 1987 Crapo 1981; ATS 1987
Kouris et al. 1991 [76] CS 996 913 ceiling and wall 8.4 6.1 26.8 5.1 nr 17.6 19.1 X-ray ATS 1979 Crapo 1981
Lilis et al. 1991 [59]* CS 2790 1536 asbestos
insulation
nr nr 35.1 7.2§ 46.6 nr nr X-ray ATS 1987 ATS 1987
Nakadate et al. 1995 [77] FU 242 27 asbestos
industry
nr nr nr nr 26.9 nr nr X-ray ATS 1978 Pneumoconiosis law of
Japan 1978
Neri et al. 1996 [25] CS 119 38 diverse 10.9 6.1 24.5 5.7 26.3 14.0 11.9 X-Ray/HRCT ATS 1987 Paoletti 1985
Niebecker at al. 1995 [9] CS 382 194 diverse nr nr nr nr 28.9 nr nr X-ray according to
ERS/ATS
EGKS 1971
Ohar et al. 2004 [4] CS 3383 3240 diverse nr nr 41.1 10.3 21.8 38.9 29.4 X-ray ATS 1987 ATS 1987
Oldenburg et al. 2001
[26]
CS 43 43 diverse 30.7 nr nr nr 27.9 nr nr X-ray and CT ATS 1987 Brändli 1996
Oliver et al. 1988 [56] CS 383 359 railway 29.2 13.4 35.6 15.0 26.2 23.4 25.1 X-ray ATS 1979,1987 Crapo 1981
Paris et al. 2004 [17] CS 706 51 asbestos
industry
24.9 9.1 nr nr #31.4 nr nr X-ray/HRCT ATS 1986 Quanjer 1993
Petrovic et al. 2004 [18] CS 120 120 asbestos cement
fabric
20.0 9.8 nr nr 100 - - X-ray CECA 1972 Quanjer 1993
Piirilä et al. 2005 [78] CS 590 367 diverse #25.7 9.4 nr nr 3.0 #21.0 13.7 HRCT ERS (Quanjer
1992)
Viljanen 1982
Prince et al. 2008 [79] CS 19 19 diverse nr nr nr nr 15.8 23.5 14.5 X-ray/CT ATS 2005 Knudson 1983
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6Table 1 Characteristics of included studies (Continued)
Robins and Green 1988
[57]
CS 182 73 asbestos
industry
30.2 nr nr nr 18.8 22.9 16.3 X-ray Crapo 1981 Crapo 1981
Rösler and Woitowitz
1990 [19]
CS 144 20 diverse 15.6 6.0 nr nr 100 - - X-ray according to
ERS/ATS
Quanjer 1983
Rui et al. 2004 [61] FU 103 103 diverse 25.0 7.0 nr nr 36.0 nr nr HRCT CECA 1971 Quanjer 1983
Schwartz et al. 1990 [58] CS 1211 1209 sheet metal 32.7 6.7 nr nr 20.3 26.9 29.4 X-ray ATS 1972 Knudson 1983
Schwartz et al. 1993 [33] CS 60 60 sheet metal >= 1 nr >=
20
nr 22.0 28.2 23.0 X-ray ATS 1979 Moris 1971; Goldman
1959
Sette et al. 2004 [80] CS 87 82 cement/
chrysotile miner
#13.4 11.7 nr nr nr #30.7 21.9 CT ATS 1995 Pereira 1992
Vierikko et al. 2010 [81] CS 627 86 diverse #18.2 11.7 #43.3 6,7 #16,9 #15.5 16,9 HRCT according to
ERS/ATS
Viljanen 1982
Zejda 1989 [82] CS 81 56 asbestos cement
industry
17.4 6.9 nr nr 16.1 nr nr X-ray CECA 1965 Quanjer 1993
Main characteristics of the Studies included in the meta-analysis. SD: standard deviation, CI: confidence interval CC: Case-control, CS: Cross-sectional; FU: follow-up; nr: not reported; m: median; r: range; X-Ray: chest
X-ray; HRCT: high resolution computer tomography; CT: computer tomography; #:for the included subjects; §: calculated from SE. *Additional information obtained from [83]
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6Figure 2 Forest plot of FVC (expressed as percent predicted with 95%CI) in asbestos-exposed collectives grouped according to the
radiological status. 2A shows the subgroups without asbestos-related diseases, 2B shows the subgroups with pleural fibrosis and 2C shows the
subgroups with asbestosis.
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Page 7 of 16Figure 3 Forest plot of FEV1 (expressed as percent predicted with 95%CI) in asbestos-exposed collectives grouped according to the
radiological status. 3A shows the subgroups without asbestos-related diseases, 3B shows the subgroups with pleural fibrosis and 3C shows the
subgroups with asbestosis.
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Page 8 of 16Figure 4 Forest plot of FEV1/FVC (expressed as percent predicted with 95%CI) in asbestos-exposed collectives grouped according to
the radiological status. 4A shows the subgroups without asbestos-related diseases, 4B shows the subgroups with pleural fibrosis and 4C shows
the subgroups with asbestosis.
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Page 9 of 16Heterogeneity was considerable (I
2 >60%) but not as
pronounced as for the other lung function parameters.
Subgroup analysis and meta-regression
Smoking
Few studies reported estimates stratified by smoking sta-
tus and radiological category. The proportion of never-
smokers was reported in 27 studies. The lung function
estimates derived from the subgroup analysis showed
greater impairment among studies with more than 25%
of participants reporting to be never-smokers for sub-
jects without radiological evidence of asbestos-related
disease and in those with pleural fibrosis (Table 3). In
the group of workers showing radiological evidence of
asbestosis lung function impairments were strongest and
a bit more pronounced in the subgroup of studies with
a lower proportion of never-smokers.
In the regression analysis of the effect of the propor-
tion of non-smokers on estimates of FEV1, those studies
with a higher proportion of never-smokers tended to
show less impairment of this parameter (not statistically
significant) for all three radiological categories.
Table 4 shows the results of three studies [24-26]
reporting estimates for non-smokers and smokers
Table 2 Estimates of lung function according to radiological findings
Overall Studies with X-ray Studies with (HR)CT
n Estimate 95% CI I
2 (%) n Estimate 95% CI I
2 (%) n Estimate 95% CI I
2 (%)
FVC (% predicted)
Normal imaging 15 95.7 93.9-97.3 94.8 9 94.9 92.9-96.9 96.2 6 97.1 94.2-100.1 89.1
Pleural fibrosis 14 89.0 86.5-91.5 96.1 8 87.1 83.9-90.4 89.5 6 91.6 87.8-95.4 96.8
Asbestosis 20 86.5 83.7-89.4 98.2 10 84.8 80.8-88.8 98.9 10 88.5 84.3-92.7 95.8
FEV1 (% predicted)
Normal imaging 14 93.6 90.6-96.5 97.3 8 91.4 87.7-95.1 98.0 6 97.4 92.5-102.2 64.7
Pleural fibrosis 11 89.2 84.7-93.7 93.7 5 83.9 77.2-90.5 42.0 6 93.7 87.6-99.9 95.8
Asbestosis 17 85.7 80.6-90.7 98.8 7 85.5 77.8-93.1 99.5 10 85.8 79.2-92.5 80.8
FEV1/FVC (% predicted)
Normal imaging 3 96.4 94.3-98.5 86.9 2 97.4 92.5-102.2 64.7 1 94.9 86.8-103.0 -
Pleural fibrosis 5 95.4 92.7-98.1 68.7 2 93.7 87.6-99.9 95.8 3 96.3 92.6-100.1 68.1
Asbestosis 8 95.5 94.1-96.9 83.8 3 85.8 79.2-92.5 80.8 5 97.0 95.7-98.3 0.0
Comparison of imaging procedure.
Estimates for forced vital capacity (FVC), forced expiratory volume in the first second (FEV1) and the ratio of both parameters (FEV1/FVC) for each radiological
subgroup. Results are shown for all included studies as well as separated according to the radiological method used for the diagnosis (conventional chest X-ray
or (high resolution) computed tomography. Estimates are expressed as percent predicted together with confidence interval (CI) and I2 as a measure of
heterogeneity, n = number of studies included in each subgroup.
Table 3 Estimates of lung function according to radiological findings
Overall Studies with <25% non-smokers Studies with >25% non-smokers
n Estimate 95% CI I
2 (%) n Estimate 95% CI I
2 (%) n Estimate 95% CI I
2 (%)
FVC (% predicted)
Normal imaging 14 96.1 93.9-98.2 95.1 6 98.1 94.6-101.6 88.0 8 94.9 92.3-97.5 96.6
Pleural fibrosis 12 90.3 87.4-93.3 96.5 6 93.2 88.9-97.5 95.9 6 87.7 83.7-91.8 95.4
Asbestosis 18 86.4 83.2-89.6 98.1 12 85.9 81.9-89.8 83.7 6 87.4 81.9-92.7 98.9
FEV1 (% predicted)
Normal imaging 13 93.9 90.0-97.8 97.4 5 97.5 90.9-104.1 35.4 8 92.0 87.2-96.8 98.3
Pleural fibrosis 10 89.9 84.1-95.7 93.6 5 91.5 83.2-99.9 96.3 5 88.5 80.4-96.5 86.2
Asbestosis 16 85.2 81.4-89.1 98.9 11 84.2 79.5-88.8 92.2 5 87.6 80.7-94.4 97.5
FEV1/FVC (% predicted)
Normal imaging 2 95.4 94.6-96.2 0.0 2 95.4 94.6-96.2 0.0 - - -
Pleural fibrosis 4 95.4 91.5-99.3 62.5 2 95.9 90.6-101.3 74.9 2 94.9 89.2-110.5 73.2
Asbestosis 8 95.6 93.2-97.9 83.8 4 96.3 94.2-98.4 55.3 4 95.3 92.2-98.3 89.8
Subgroup analysis according to % of never-smokers.
Estimates for forced vital capacity (FVC), forced expiratory volume in the first second (FEV1) and the ratio of both parameters (FEV1/FVC) for each radiological
subgroup. Results are shown for all included studies as well as separated according to the proportion of non-smokers included in each subgroup (less ore more
than 25%). Estimates are expressed as percent predicted together with confidence interval (CI) and I2 as a measure of heterogeneity, n = number of studies
included in each subgroup.
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These papers suggest mainly a synergistic effect of
smoking and asbestos exposure.
Duration of asbestos exposure
Mean exposure duration was reported in 23 studies. The
data was heterogeneous (Table 5). FEV1 was consistently
better across all radiological categories in the subgroup
of studies with a mean exposure length of more than 22
years. In contrast, FEV1/VC was consistently better
across all radiological subgroups for the studies with
shorter mean exposure duration. The results for FVC
were inconsistent. The regression analysis, however,
indicated that lower FVC and FEV1 could be expected
with increasing mean exposure duration.
Discussion
Several population-based studies provide evidence of
asbestos exposure contributing significantly to the bur-
den of airway diseases, but a detailed assessment of
exposure was generally neither presented nor performed
in such studies [27-29]. The pleural plaque incidence in
the general population is in the range of 0.02 to 12.8%
[30] and is 80-90% attributable to asbestos exposure
[31]. The initial concern about the potential adverse
effects of asbestos on lung function was vindicated in
clinical as well as epidemiologic studies over many years
[12,13]. The present meta-analysis has considered the
major lung function parameters VC, FEV1, FEV1/VC, for
asbestos-exposed workers grouped, according to their
radiological diagnosis, into three groups: “absence of
pleural and lung parenchymal fibrosis”,d i a g n o s e dw i t h
“pleural fibrosis” (PP and/or DPT) or “asbestosis with or
without pleural fibrosis”. Overall, our analysis shows a
statistically significant reduction of VC, FEV1 and FEV1/
VC among workers exposed to asbestos compared to
the general population (i.e. reference values).
The severity of the observed impairments is related to
the degree of radiological abnormalities indicative of
pleural fibrosis and asbestosis. Overall, VC and FEV1
scores were lowest for those workers showing radiologi-
cal findings of asbestosis, followed by those with signs
of pleural fibrosis. Workers exposed to asbestos with
normal radiological findings (either X-ray or (HR)CT)
exhibited significantly better VC and FEV1 scores than
those with radiological abnormalities, but their
decreased values indicate some degree of lung function
Table 4 Asbestos-exposed workers without radiological
evidence of parenchymal disease stratified by smoking
status
Non-smokers Smokers
Studie n %
predicted
SD n %
predicted
SD
Hall 1982 FEV1 46 101.0 13.6 67 92.5 14.9
FVC 102.2 11.6 99.2 13.4
Neri 1996 FEV1 34 90.9 15.6 47 92.0 14.0
FVC 89.7 14.9 90.9 14.3
FEV1/
FVC
100.3 10.9 100.2 6.8
Oldenburg
2001
FEV1 12 105.7 13.6 31 83.6 25.1
FVC 96.1 10.9 86.7 12.6
FEV1/
FVC
102.3 4.39 94.5 18.6
Differences in forced vital capacity (FVC), forced expiratory volume in the first
second (FEV1) and the ratio of both parameters (FEV1/FVC) between asbestos
exposed non-smokers and smokers without radiological evidence of
asbestosis. Estimates expressed as percent predicted together with standard
deviation (SD) and I2 as a measure of heterogeneity, n = number of subjects
included in each subgroup.
Table 5 Estimates of lung function according to radiological findings
Overall Studies <22 yr. mean exposure Studies >22 yr. mean exposure
n Estimate 95% CI I
2 (%) n Estimate 95% CI I
2 (%) n Estimate 95% CI I
2 (%)
FVC (% predicted)
Normal imaging 11 96.2 94.4-98.0 95.9 4 97.0 94.2-99.8 96.5 7 95.7 93.4-98.0 90.8
Pleural fibrosis 11 89.2 85.6-92.8 96.9 2 81.8 73.2-90.3 92.8 9 90.8 86.8-94.8 98.0
Asbestosis 12 87.4 82.2-92.6 95.5 5 87.9 79.9-95.9 96.1 7 87.0 80.2-93.9 95.0
FEV1 (% predicted)
Normal imaging 11 93.7 89.3-98.1 97.9 5 91.8 85.5-98.1 97.4 6 95.5 89.3-101.7 96.1
Pleural fibrosis 9 89.2 83.9-94.5 94.8 2 84.7 73.5-95.8 35.5 7 90.6 84.6-96.5 95.5
Asbestosis 10 86.8 82.3-91.2 84.2 5 86.4 80.3-92.5 90.4 5 87.1 80.6-93.6 66.7
FEV1/FVC (% predicted)
Normal imaging 3 96.4 94.3-98.5 86.9 2 96.5 94.3-98.7 93.4 1 94.9 86.2-103.6 -
Pleural fibrosis 4 95.5 92.9-96.2 68.2 1 96.2 94.4-97.8 - 3 93.8 91.9-95.8 48.1
Asbestosis 7 95.8 93.8-97.9 86.1 3 97.7 95.9-99.5 0.0 4 94.6 92.0-97.2 83.2
Subgroup analysis by mean exposure duration.
Differences in forced vital capacity (FVC), forced expiratory volume in the first second (FEV1) and the ratio of both parameters (FEV1/FVC) between subgroups
with a mean exposure duration of less (<22 yr.) and more for than 22 years (>22 yr.). Results are shown for each radiological subgroup. Estimates are expressed
as percent predicted together with confidence interval (CI) and I2 as a measure of heterogeneity, n = number of studies included in each subgroup.
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Page 11 of 16impairment. FEV1/VC was slightly reduced in all groups.
This reduction was more evident in the subgroups with
radiological abnormalities. These differences between
groups persisted mostly when the studies were analysed
separately, according to the radiological methods used
(either X-ray or (HR)CT), although less pronounced for
the (HR)CT-based studies of the three subgroups of
patients. In general, studies with (HR)CT based diagno-
sis report milder lung function impairments than those
using conventional X-ray due to the higher sensitivity of
the (HR)CT for mild grades of pleural disorders and
asbestosis.
A positive relationship between the severity of func-
tional impairment and the radiologically defined degree
(score) of asbestos-related pleural and/or pulmonary
fibrosis was already reported in a few studies [32-34]. As
shown the absence of characteristic radiological findings
does not exclude lung function abnormalities. Our
meta-analysis revealed statistically significant deteriora-
tion in the lung function parameters for asbestos work-
ers without any evidence of radiological abnormalities.
These findings extend the meta-analysis by Filippelli,
Martines et al [35] who found statistically significant
reductions in all investigated lung function parameters
in subjects exposed to asbestos, although the authors
did not account for different radiological findings.
Regression models reported in some of the included stu-
dies indicate that the radiological findings can only
explain a small part of the variability in these para-
meters. Other authors have also reported a medium to
low explanatory power of radiological findings for other
lung function parameters [33,32].
There is evidence from clinical studies that discrepan-
cies between lung function and radiological findings can
be due to asbestos-induced pulmonary alterations not
radiologically detectable. These studies describe multiple
cellular lesions, apoptosis, inflammatory and profibro-
genic responses, using histopathology and electron
microscopy, as well as the synthesis of associated media-
tors and oxygen radicals [36-40]. It has been estimated
that exposure to an asbestos fibre dose [41] of 25 fibre-
years represents the inhalation of about 55 billion asbes-
tos fibres [42], of which a significant proportion is
deposited in the lung.
Our findings indicate not only the presence of restric-
tive but also of obstructive ventilation patterns in work-
ers exposed to asbestos, either with or without asbestos-
related radiological abnormalities: an issue of controver-
sial discussion.
Recently, Dement et al. [43] found an overall COPD
prevalence of 18.9% in asbestos workers/insulators. In
their collective of older construction and trade workers,
at the US Department of Energy with mixed exposure at
nuclear sites, the prevalence of COPD was of 23%
among those only with pleural changes and 32.3%
among those with both pleural and parenchymal
changes [43]. Conversely, Ameille et al. [44] reported a
lack of association between occupational exposure to
asbestos and airway obstruction. They determined that
FEV1/FVC and FEV25-75 did not differ through the
cumulative exposure classes and there was no significant
correlation between cumulative exposure to asbestos
and pulmonary function parameters nor with the pro-
portion of abnormal pulmonary function tests [44].
However, these authors did not include a non-exposed
control group and report generally elevated values for
FVC, FEV1,F E V 1/FVC and residual volume (RV), which
can be explained by the selected study population
(volunteers for a screening programme without previous
severe respiratory disease).
Bias and limitations
The degree of lung function impairment may have been
underestimated due to bias in the included studies. Two
main sources of not negligible underestimation of
adverse health effects in actual occupational cohort stu-
dies are the dilution effect and the comparison bias
[45]. The dilution effect results from the inclusion of
not or very low exposed workers in the study cohort.
T h ec o m p a r i s o nb i a sr e s u l t sf r o mah e a l t h yh i r ee f f e c t s
at the beginning of exposure history. The lung function
of blue collar workers - like the ones included in our
study - is typically better than the references taken from
the general population (i.e. over 100% predicted)
[46,47]. In those workers lung function values studied at
a single time point may be still within the norm despite
an underlying considerable absolute decrease since the
start of exposure (e.g. a FEV1 fall from 115% to 95%).
Comparison bias results also from the healthy worker
effect in the course of the working life. Subjects with
relevant health impairments may change their occupa-
tion or have a shortened work life and thus may not be
available for recruiting to later lung function assessment
based on occupation or worksite. For example Fell et al.
[48] hypothesized in their investigation on respiratory
symptoms and ventilatory function of workers exposed
to cement dust that individuals susceptible to adverse
respiratory effects from cement dust may have quitted
work and therefore dropped out of the exposed groups.
The authors found a high prevalence (55%) of respira-
tory symptoms and COPD in the group of former
cement workers visited at home, underlying the impor-
tance of included former workers. These biases are
probably present in the studies included in our sys-
tematic review, since most of them had a cross-sec-
tional design not accounting for changes in lung
function over time and in general did not consider for-
mer workers.
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geneity (high I
2) across the studies, which we acknowl-
edged by using a random effects model. Heterogeneity is
caused by variations in the individual study populations
as well as differences in study methods.
With respect to the study design, a major source of
heterogeneity is the quality of lung function tests and
the variety of references values used in the studies. We
included predicted values, as given by the various
authors with their considerable variation. For example,
the reference values of Quanjer et al. [20,21] have been
shown to be at least 10% too low for current normal
populations [49-53], thus leading to an underestimation
of the effects of asbestos exposure. The same is true for
some other reference values based on inadequate refer-
ence populations.
The issue of the study population as a source of het-
erogeneity includes the following aspects: First, studies
differed considerably in the duration of occupational
exposure to asbestos, ranging from less than 1 year to
over 30 years. The subgroup analysis indicated that the
results for FEV1 and for FEV1/VC were negatively
related to the duration of exposure. The meta-regres-
sion analysis indicated an inverse relationship between
exposure duration and FVC and FEV1 (i.e. lower esti-
mates with increasing mean exposure duration). How-
ever, this can only explain a small amount of
heterogeneity. There are also major differences between
studies regarding the intensity of exposure because of
the wide variety of tasks and occupations studied. Since
only two studies [41,54] reported an estimation of expo-
sure intensity (i.e. fibre-years), we could not explore this
source of heterogeneity in subgroup or regression analy-
sis. Similarly, mean latency times were only reported in
nine of the included studies, thus subgroup analysis or
meta-regression to explore heterogeneity could not be
performed.
An additional source of heterogeneity may be the dif-
ferences in the distribution of confounders, such as
smoking or co-exposure to other occupational noxae.
Regarding co-exposures most of the studies provided lit-
tle information and we could not explore this potential
source of heterogeneity in detail.
An important question concerns the interaction
between smoking and asbestos exposure. Only a few
studies accounted for smoking in their analysis appro-
priately. In one of the two studies that included only
never-smokers [18], reduced VC was reported for both
asbestos-exposed workers without and with pleural
fibrosis, and an impairment of FEV1 was seen in those
with pleural fibrosis. The other study considering only
never-smokers examined patients with asbestosis. Here
all lung function parameters were correspondingly
impaired [19].
Niebecker and colleagues showed for patients with
asbestosis that the degree of impairment was greater
among smokers [9]. Some of the included studies
[16,33,55-61] reported multivariate linear regression
models including smoking as an explanatory variable
(among others). The results of these analyses suggest an
association of lung function impairments with pleural
abnormalities independent of smoking, i.e. when pleural
fibrosis is present then impairments in lung function
can be observed in both smokers and non-smokers.
At the study level, the results of subgroup analysis
according to the proportion of never-smokers were
inconsistent and partly counterintuitive, since for some
parameters, the higher the proportion of non-smokers
in a study, the lower were the estimates. An additional
analysis using the mean pack-years - as an indication of
the dose - was not performed, because one third of the
included studies did not report the information.
Therefore our approach does not allow a clear differ-
entiation of smoking effects from those of asbestos,
mainly due to the shortcomings or the failure to report
findings of the included studies but provides evidence
that the observed impairment in lung function in the
absence of radiological signs of asbestos-related par-
enchymal disease cannot be attributed solely to smoking
and that asbestos exposure plays a causal role.
A recent meta-analysis [35], which did not consider
radiological findings, demonstrated independent signifi-
cant effects of smoking as well as of asbestos exposure
(i.e. a synergistic effect), both for forced expiratory flow
(FEF25-75,F E F 50) as well as thoracic gas volume (TGV)
and RV/TGV. In this analysis, the influence of asbestos
exposure was stronger than that of smoking for FEV1/
VC and airway resistance, whereas smoking had a stron-
ger effect on FEF25-75. Evidence for a synergistic detri-
mental effect of smoking and asbestos exposure on
airflow limitation has also been reported in several addi-
tional studies (FEV1 [62,41,61,63,64], FEV1/VC
[65,66,9,10,4,25,61,26], FEF25-75 [66,3,25,10,43] and
FEF75-85 [66,3]).
It has to be acknowledged that our study does not
allow answering the question whether the observed sta-
tistically significant lung function impairments at the
population level are also of clinical relevance at the indi-
vidual level. Indeed, in clinical practice the diagnosis of
an obstructive defect requires a FEV1/FVC of less than
70% and a FEV1 over 80% from predicted is considered
to represent mild impairment in an individual [67]. Our
pooled estimates are within the normal limits applied to
individuals (even when considering the lower limits of
the confidence interval). Small decreases in group mean
values however do not preclude clinically important dis-
ease. For example a group of workers exposed to asbes-
tos with moderate dyspnoea had mean FVC of 96%,
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dicted [68], which are similar to our pooled estimates.
In one study, lung function impairments, particularly
airflow obstruction, have been associated with increased
mortality in asbestos exposed workers [69].
Conclusions
We conclude that asbestos exposure causes restrictive as
well as obstructive lung function impairment. Asbestos-
exposed workers may present lung function impair-
ments even in the absence of radiological evidence of
asbestos-related pleural fibrosis or asbestosis.
Our systematic review demonstrates that despite the
large number of studies about the health hazards from
occupational exposure to asbestos, there is a need for
further research, especially on the role of smoking,
occupational co-exposure (e.g. other mineral dusts,
welding fumes) and possible synergistic effects on the
development of functional impairment, particularly
chronic airway obstruction, in asbestos-exposed workers.
Such studies should include measurement of CO diffu-
sion capacity, airway resistance and flow volume curves
in a consistent approach. Furthermore, our study under-
lines the necessity for an international agreement on
lung function reference values within the individual eth-
nic groups, to facilitate comparison between different
studies.
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